What's needed for personalized therapy in smoking cessation

Clinical Pharmacology and Therapeutics
R S Epstein

Abstract

It has long been known that smoking cessation is one of the most cost-effective public health opportunities available. The fact that some 22% of Americans smoke,(1) despite overwhelming evidence of the consequences, reflects in part the addictive aspects of smoking and the generally modest effectiveness of various strategies for quitting. Although one of the US Department of Health and Human Services goals for the year 2010 is universal coverage of smoking-cessation agents,(2) only about a third of payers currently cover the cost of such agents.(3) A major disincentive is that the return on investment has been modeled to take at least 5 years to reach the break-even point,(4,5) given the cost of the individual agents, the high recidivism rates, the timeline for influencing outcomes, and the relative ineffectiveness of studied agents in broad or untargeted populations. The article by Patterson et al.(6) in this issue intriguingly suggests that there might be a way to use smokers' phenotypes to determine before treatment initiation which smokers will respond to which therapy. This approach could greatly improve the overall effectiveness of smoking-cessation agents and generate cost savings that might in turn have the effect of in...Continue Reading

References

Aug 12, 2000·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·M T HalpernC Battista
Jan 16, 2007·Biological Psychiatry·Anna M LeeRachel F Tyndale
Apr 5, 2008·Clinical Pharmacology and Therapeutics·F PattersonC Lerman

❮ Previous
Next ❯

Citations

Oct 30, 2016·Journal of Neurosurgery·C Eduardo CorralesRobert K Jackler
Jun 6, 2009·Therapeutic Advances in Cardiovascular Disease·William H Frishman
May 19, 2010·Expert Review of Respiratory Medicine·Kathleen F Harrington, William C Bailey
May 22, 2016·Neuroscience Letters·Li-Shiun ChenLaura Bierut

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.